Early detection and interception of pancreatic ductal adenocarcinoma (PDAC) remain the only realistic strategies to reduce mortality and meaningfully extend survival.1 Among established precursors, ...

Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005 This international ...

Influence of underlying liver disease on response to sorafenib in patients with advanced hepatocellular carcinoma (HCC). Methods: An epidemiologic questionnaire was administered to patients (pts) with ...

An intraductal papillary mucinous neoplasm (IPMN) is a benign or noncancerous cyst in the ducts of the pancreas. The cysts are sometimes precancerous, which means they may lead to pancreatic cancer.

The Fukuoka guidelines state that imaging findings indicative of malignancy are high-risk stigmata/worrisome features in the management of patients with intraductal papillary mucinous neoplasm (IPMN).

How Do Precancerous Lesions Develop Towards Pancreatic Cancer? Pancreatic cancer is one of the deadliest diseases in United States, with a 5-year survival of 12% and is considered to be one of the ...

IPMN tumors are being recognized with increasing frequency and appear to have a better prognosis than adenocarcinoma of the pancreas. This report highlights the increased risk for other benign or ...

Researchers report two breakthroughs in understanding pancreatic cancer: the development of the first mouse model that simulates a precursor lesion called intraductal papillary mucinous neoplasia ...

The majority of pancreatic cancers are thought to evolve through a series of hyperplastic and dysplastic ductal lesions termed PanIN. Normal ductal epithelium progresses to invasive adenocarcinomas ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — If a branch duct-intraductal papillary mucinous neoplasm grows at a rate of 5 mm or more annually, ...